SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
-6.57%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$95.9M
AUM Growth
+$95.9M
(-7.4%)
Cap. Flow
+$2.62M
Cap. Flow
% of AUM
2.73%
Top 10 Holdings %
Top 10 Hldgs %
62.51%
Holding
48
New
11
Increased
11
Reduced
6
Closed
9
Top Buys
| 1 |
GSK
GSK
|
$6.96M |
| 2 |
Edwards Lifesciences
EW
|
$5.15M |
| 3 |
Eli Lilly
LLY
|
$4.93M |
| 4 |
Zimmer Biomet
ZBH
|
$4.82M |
| 5 |
Aclaris Therapeutics
ACRS
|
$3.76M |
Top Sells
| 1 |
Sanofi
SNY
|
$8.53M |
| 2 |
Philips
PHG
|
$7.74M |
| 3 |
Cardinal Health
CAH
|
$4.68M |
| 4 |
Medpace
MEDP
|
$3.47M |
| 5 |
ANTH
Anthera Pharmaceuticals, Inc.
ANTH
|
$2.84M |
Sector Composition
| 1 | Healthcare | 78.11% |
| 2 | Industrials | 6.06% |
| 3 | Financials | 2.59% |
| 4 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QTNT
1
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $10.8M | 6.32% | 2,237,771 +52,102 | +2% | +$252K |
|
|
2
GSK
GSK
$79.9B
| $6.96M | 4.06% | +180,811 | New | +$6.96M |
|
|
3
Philips
PHG
$26.2B
| $6.4M | 3.74% | 209,502 -253,160 | -55% | -$7.74M |
|
|
HRC
4
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $5.98M | 3.49% | 106,594 +45,295 | +74% | +$2.54M |
|
|
TRHC
5
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $5.81M | 3.39% | 388,054 -121,946 | -24% | -$1.83M |
|
|
6
Edwards Lifesciences
EW
$47.8B
| $5.15M | 3.01% | +55,000 | New | +$5.15M |
|
|
7
Cardinal Health
CAH
$35.5B
| $4.96M | 2.89% | 68,885 -65,052 | -49% | -$4.68M |
|
|
8
Eli Lilly
LLY
$657B
| $4.93M | 2.88% | +67,000 | New | +$4.93M |
|
|
9
Zimmer Biomet
ZBH
$21B
| $4.82M | 2.81% | +46,723 | New | +$4.82M |
|
|
AAAP
10
DELISTED
Advanced Accelerator Applications S.A. American Depositary Shares
AAAP
| $4.1M | 2.39% | 153,332 +77,775 | +103% | +$2.08M |
|
|
11
Aclaris Therapeutics
ACRS
$209M
| $3.76M | 2.19% | +138,441 | New | +$3.76M |
|
|
DMK
12
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $3.31M | 1.93% | 1,051,063 +385,608 | +58% | +$1.21M |
|
|
NTUS
13
DELISTED
Natus Medical Inc
NTUS
| $3.16M | 1.84% | 90,865 +34,865 | +62% | +$1.21M |
|
14
Rigel Pharmaceuticals
RIGL
$697M
| $3.01M | 1.75% | 1,263,390 +242,671 | +24% | +$578K |
|
15
UnitedHealth
UNH
$281B
| $2.59M | 1.51% | 16,187 +1,138 | +8% | +$182K |
|
|
AET
16
DELISTED
Aetna Inc
AET
| $2.48M | 1.45% | +20,000 | New | +$2.48M |
|
17
Boston Scientific
BSX
$156B
| $2.46M | 1.43% | +113,500 | New | +$2.46M |
|
18
Perrigo
PRGO
$3.27B
| $2.44M | 1.42% | 29,329 -9,624 | -25% | -$801K |
|
|
CCXI
19
DELISTED
ChemoCentryx, Inc.
CCXI
| $2.41M | 1.4% | 325,250 -288,640 | -47% | -$2.14M |
|
20
Amgen
AMGN
$155B
| $2.4M | 1.4% | +16,430 | New | +$2.4M |
|
|
IMMU
21
DELISTED
Immunomedics Inc
IMMU
| $1.86M | 1.09% | +506,978 | New | +$1.86M |
|
22
Actinium Pharmaceuticals
ATNM
$55.5M
| $1.44M | 0.84% | 1,649,078 +49,078 | +3% | +$42.9K |
|
|
ADMS
23
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $1.17M | 0.68% | 69,215 +3,105 | +5% | +$52.5K |
|
|
AVDL
24
Avadel Pharmaceuticals
AVDL
$1.43B
| $950K | 0.55% | +91,413 | New | +$950K |
|
25
Spyre Therapeutics
SYRE
$996M
| $820K | 0.48% | 188,485 +34,153 | +22% | +$149K |
|